Cancer Causes & Control

, Volume 25, Issue 10, pp 1329–1336

Colonoscopy reduced distal colorectal cancer risk and excess cancer risk associated with family history

  • Sophie Morois
  • Vanessa Cottet
  • Antoine Racine
  • Françoise Clavel-Chapelon
  • Franck Carbonnel
  • Nadia Bastide
  • Marie-Christine Boutron-Ruault
Original paper

Abstract

Purpose

Colonoscopy efficacy at preventing proximal colorectal cancer (CRC) is questioned, and little is known about efficacy in high-risk versus medium-risk populations. We investigated the relationship between colonoscopy screening, family history of colorectal cancer (FHCC), and CRC risk by site.

Methods

Among 92,078 women of the E3N prospective cohort, 692 CRCs have been diagnosed after a median follow-up of 15.4 years. Cox proportional hazard models estimated adjusted hazards ratios according to subsites of cancer and FHCC.

Results

A personal history of colonoscopy (PHC; n = 37,470) was associated with decreased rectal and distal colon cancer risks (hazard ratio (HR) = 0.57; 95 % Confidence Interval (CI) = 0.42–0.78 and HR = 0.37; 95 % CI = 0.26–0.52, respectively), but not proximal colon cancer risk (HR = 0.87; 95 % CI = 0.64–1.18). In women with no prior colonoscopy, those with FHCC had a 80 % higher CRC risk than those without FHCC. In women with previous colonoscopy, CRC risk was similar in women with and without FHCC (p for interaction = 0.04).

Conclusions

Results showed colonoscopy ability to prevent distal cancers, but not proximal cancers in women. Colonoscopy screening also reduced the excess risk of women with FHCC to that of women with no FHCC.

Keywords

Colorectal cancer Colonoscopy Family history Prospective study Screening Efficacy 

References

  1. 1.
    Belot A, Grosclaude P, Bossard N et al (2008) Cancer incidence and mortality in France over the period 1980–2005. Rev Epidemiol Sante Publique 56:159–175PubMedCrossRefGoogle Scholar
  2. 2.
    Mazeau-Woynar V, Cerf N (2010) Survie attendue des cancers en France : état des lieux. INCaGoogle Scholar
  3. 3.
    Elmunzer BJ, Hayward RA, Schoenfeld PS, Saini SD, Deshpande A, Waljee AK (2012) Effect of flexible sigmoidoscopy-based screening on incidence and mortality of colorectal cancer: a systematic review and meta-analysis of randomized controlled trials. PLoS Med 9:e1001352PubMedCentralPubMedCrossRefGoogle Scholar
  4. 4.
    Brenner H, Hoffmeister M, Arndt V, Stegmaier C, Altenhofen L, Haug U (2010) Protection from right- and left-sided colorectal neoplasms after colonoscopy: population-based study. J Natl Cancer Inst 102:89–95PubMedCrossRefGoogle Scholar
  5. 5.
    Singh H, Nugent Z, Demers AA, Kliewer EV, Mahmud SM, Bernstein CN (2010) The reduction in colorectal cancer mortality after colonoscopy varies by site of the cancer. Gastroenterology 139:1128–1137PubMedCrossRefGoogle Scholar
  6. 6.
    Singh H, Turner D, Xue L, Targownik LE, Bernstein CN (2006) Risk of developing colorectal cancer following a negative colonoscopy examination: evidence for a 10-year interval between colonoscopies. JAMA 295:2366–2373PubMedCrossRefGoogle Scholar
  7. 7.
    Brenner H, Chang-Claude J, Seiler CM, Rickert A, Hoffmeister M (2011) Protection from colorectal cancer after colonoscopy: a population-based, case–control study. Ann Intern Med 154:22–30PubMedCrossRefGoogle Scholar
  8. 8.
    Lakoff J, Paszat LF, Saskin R, Rabeneck L (2008) Risk of developing proximal versus distal colorectal cancer after a negative colonoscopy: a population-based study. Clin Gastroenterol Hepatol 6:1117–1121 quiz 1064PubMedCrossRefGoogle Scholar
  9. 9.
    Schmidt C (2012) Colonoscopy vs sigmoidoscopy: new studies fuel ongoing debate. J Natl Cancer Inst 104:1350–1351PubMedCrossRefGoogle Scholar
  10. 10.
    Kavanagh AM, Giovannucci EL, Fuchs CS, Colditz GA (1998) Screening endoscopy and risk of colorectal cancer in United States men. Cancer Causes Control 9:455–462PubMedCrossRefGoogle Scholar
  11. 11.
    Dove-Edwin I, Sasieni P, Adams J, Thomas HJ (2005) Prevention of colorectal cancer by colonoscopic surveillance in individuals with a family history of colorectal cancer: 16 year, prospective, follow-up study. BMJ 331:1047PubMedCentralPubMedCrossRefGoogle Scholar
  12. 12.
    Hunt LM, Rooney PS, Hardcastle JD, Armitage NC (1998) Endoscopic screening of relatives of patients with colorectal cancer. Gut 42:71–75PubMedCentralPubMedCrossRefGoogle Scholar
  13. 13.
    Syrigos KN, Charalampopoulos A, Ho JL, Zbar A, Murday VA, Leicester RJ (2002) Colonoscopy in asymptomatic individuals with a family history of colorectal cancer. Ann Surg Oncol 9:439–443PubMedCrossRefGoogle Scholar
  14. 14.
    Clavel-Chapelon F, van Liere MJ, Guibout C et al (1997) E3N, a French cohort study on cancer risk factors. E3N Group. Etude Epidemiologique aupres de femmes de l’Education Nationale. Eur J Cancer Prev 6:473–478PubMedCrossRefGoogle Scholar
  15. 15.
    Hoffmeister M, Chang-Claude J, Brenner H (2007) Validity of self-reported endoscopies of the large bowel and implications for estimates of colorectal cancer risk. Am J Epidemiol 166:130–136PubMedCrossRefGoogle Scholar
  16. 16.
    Nishihara R, Wu K, Lochhead P et al (2013) Long-term colorectal-cancer incidence and mortality after lower endoscopy. N Engl J Med 369:1095–1105PubMedCrossRefGoogle Scholar
  17. 17.
    Mulder SA, van Soest EM, Dieleman JP et al (2010) Exposure to colorectal examinations before a colorectal cancer diagnosis: a case–control study. Eur J Gastroenterol Hepatol 22:437–443PubMedCrossRefGoogle Scholar
  18. 18.
    Singh H, Nugent Z, Mahmud SM, Demers AA, Bernstein CN (2010) Predictors of colorectal cancer after negative colonoscopy: a population-based study. Am J Gastroenterol 105:663–673 quiz 674PubMedCrossRefGoogle Scholar
  19. 19.
    Muller AD, Sonnenberg A (1995) Protection by endoscopy against death from colorectal cancer. A case–control study among veterans. Arch Intern Med 155:1741–1748PubMedCrossRefGoogle Scholar
  20. 20.
    Baxter NN, Goldwasser MA, Paszat LF, Saskin R, Urbach DR, Rabeneck L (2009) Association of colonoscopy and death from colorectal cancer. Ann Intern Med 150:1–8PubMedCrossRefGoogle Scholar
  21. 21.
    Brenner H, Chang-Claude J, Seiler CM, Sturmer T, Hoffmeister M (2007) Potential for colorectal cancer prevention of sigmoidoscopy versus colonoscopy: population-based case control study. Cancer Epidemiol Biomarkers Prev 16:494–499PubMedCrossRefGoogle Scholar
  22. 22.
    Neugut AI, Lebwohl B (2010) Colonoscopy vs sigmoidoscopy screening: getting it right. JAMA 304:461–462PubMedCrossRefGoogle Scholar
  23. 23.
    Garrett KA, Church J (2010) History of hysterectomy: a significant problem for colonoscopists that is not present in patients who have had sigmoid colectomy. Dis Colon Rectum 53:1055–1060PubMedCrossRefGoogle Scholar
  24. 24.
    Kaku E, Oda Y, Murakami Y et al (2011) Proportion of flat- and depressed-type and laterally spreading tumor among advanced colorectal neoplasia. Clin Gastroenterol Hepatol 9:503–508PubMedCrossRefGoogle Scholar
  25. 25.
    Wilschut JA, Habbema JD, Ramsey SD, Boer R, Looman CW, van Ballegooijen M (2010) Increased risk of adenomas in individuals with a family history of colorectal cancer: results of a meta-analysis. Cancer Causes Control 21:2287–2293PubMedCrossRefGoogle Scholar
  26. 26.
    Sanduleanu S, Masclee AM, Meijer GA (2012) Interval cancers after colonoscopy-insights and recommendations. Nat Rev Gastroenterol Hepatol 9:550–554PubMedCrossRefGoogle Scholar
  27. 27.
    Ahlquist DA (2010) Molecular detection of colorectal neoplasia. Gastroenterology 138:2127–2139PubMedCrossRefGoogle Scholar
  28. 28.
    Launoy G, Smith TC, Duffy SW, Bouvier V (1997) Colorectal cancer mass-screening: estimation of faecal occult blood test sensitivity, taking into account cancer mean sojourn time. Int J Cancer 73:220–224PubMedCrossRefGoogle Scholar
  29. 29.
    Brenner H, Chang-Claude J, Seiler CM, Sturmer T, Hoffmeister M (2006) Does a negative screening colonoscopy ever need to be repeated? Gut 55:1145–1150PubMedCentralPubMedCrossRefGoogle Scholar
  30. 30.
    Newcomb PA, Savu A, Phipps AI, Coghill AE, Yasui Y (2012) Impact of colon cancer screening on family history phenotype. Epidemiology 23:308–310PubMedCentralPubMedCrossRefGoogle Scholar
  31. 31.
    Chauvenet M, Cottet V, Lepage C, Jooste V, Faivre J, Bouvier AM (2011) Trends in colorectal cancer incidence: a period and birth-cohort analysis in a well-defined French population. BMC Cancer 11:282PubMedCentralPubMedCrossRefGoogle Scholar
  32. 32.
    Murphy G, Devesa SS, Cross AJ, Inskip PD, McGlynn KA, Cook MB (2011) Sex disparities in colorectal cancer incidence by anatomic subsite, race and age. Int J Cancer 128:1668–1675PubMedCentralPubMedCrossRefGoogle Scholar
  33. 33.
    Cole BF, Logan RF, Halabi S et al (2009) Aspirin for the chemoprevention of colorectal adenomas: meta-analysis of the randomized trials. J Natl Cancer Inst 101:256–266PubMedCrossRefGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2014

Authors and Affiliations

  • Sophie Morois
    • 1
    • 2
  • Vanessa Cottet
    • 3
    • 4
    • 5
  • Antoine Racine
    • 1
    • 2
  • Françoise Clavel-Chapelon
    • 1
    • 2
  • Franck Carbonnel
    • 1
    • 2
    • 6
  • Nadia Bastide
    • 1
    • 2
  • Marie-Christine Boutron-Ruault
    • 1
    • 2
  1. 1.INSERM U1018, Team 9Institut Gustave Roussy, Espace Maurice TubianaVillejuif CedexFrance
  2. 2.UMRS 1018Université Paris Sud 11Villejuif CedexFrance
  3. 3.Registre Bourguignon des Cancers DigestifsUniversité de BourgogneDijonFrance
  4. 4.INSERM U866Université de BourgogneDijonFrance
  5. 5.CHU DIJONUniversité de BourgogneDijonFrance
  6. 6.Service d’HépatogastroentérologieCentre Hospitalier de BicêtreLe Kremlin BicêtreFrance

Personalised recommendations